Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus
Kahl, L., Patel, J., Layton, M., Binks, M., Hicks, K., Leon, G., Hachulla, E., Machado, D., Staumont-Salle, D., Dickson, M., Condreay, L., Schifano, L., Zamuner, S., van Vollenhoven, R. F.Language:
english
Journal:
Lupus
DOI:
10.1177/0961203316640910
Date:
April, 2016
File:
PDF, 233 KB
english, 2016